Akoya Biosciences, Inc. (AKYA)

Akoya Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	79.96	81.67	96.63	74.86	54.92	42.44
Revenue Growth (YoY)	-14.55%	-15.48%	29.09%	36.31%	29.39%	0.49%
Cost of Revenue	30.59	33.79	40.33	31.47	20.7	16.54
Gross Profit	49.37	47.88	56.31	43.39	34.22	25.91
Selling, General & Admin	67.03	69.32	87.36	79.65	51.02	23.98
Research & Development	19.75	19.75	24.97	23.21	15.7	9.6
Operating Expenses	86.78	89.06	112.34	109.6	71.44	37.4
Operating Income	-37.41	-41.18	-56.03	-66.21	-37.23	-11.49
Interest Expense	-10.31	-10.43	-8.76	-4.55	-3.12	-2.72
Interest & Investment Income	1.88	2.51	3.49	0.78	0.09	-
Other Non Operating Income (Expenses)	-2.08	-2.23	-0.35	-0.86	-3.23	-0.26
EBT Excluding Unusual Items	-47.92	-51.33	-61.65	-70.84	-43.48	-14.47
Merger & Restructuring Charges	-1.69	-3.09	-	-	-	-
Gain (Loss) on Sale of Investments	1.66	1.66	0.01	0.22	-	-
Asset Writedown	-	-2.97	-	-	-	-
Other Unusual Items	0.55	0.51	-1.64	0.1	0.4	-2.19
Pretax Income	-47.4	-55.22	-63.28	-70.52	-43.08	-16.66
Income Tax Expense	0.13	0.15	0.04	0.12	-0.14	0.04
Net Income	-47.53	-55.37	-63.32	-70.64	-42.94	-16.71
Preferred Dividends & Other Adjustments	-	-	-	-	1.44	5.06
Net Income to Common	-47.53	-55.37	-63.32	-70.64	-44.37	-21.76
Shares Outstanding (Basic)	50	49	44	38	27	2
Shares Outstanding (Diluted)	50	49	44	38	27	2
Shares Change (YoY)	5.06%	11.22%	17.72%	40.34%	1034.62%	4.15%
EPS (Basic)	-0.96	-1.12	-1.43	-1.87	-1.65	-9.18
EPS (Diluted)	-0.96	-1.12	-1.43	-1.87	-1.65	-9.18
Free Cash Flow	-32.34	-46.56	-54.55	-60.86	-41.16	-10.14
Free Cash Flow Per Share	-0.65	-0.94	-1.23	-1.61	-1.53	-4.28
Gross Margin	61.74%	58.62%	58.27%	57.96%	62.31%	61.04%
Operating Margin	-46.79%	-50.43%	-57.98%	-88.44%	-67.78%	-27.08%
Profit Margin	-59.45%	-67.79%	-65.53%	-94.36%	-80.79%	-51.27%
Free Cash Flow Margin	-40.45%	-57.01%	-56.45%	-81.29%	-74.95%	-23.89%
EBITDA	-30.01	-33.53	-47.14	-59.06	-32.43	-7.68
EBITDA Margin	-37.53%	-41.05%	-48.78%	-78.89%	-59.06%	-18.09%
D&A For EBITDA	7.4	7.65	8.89	7.15	4.79	3.82
EBIT	-37.41	-41.18	-56.03	-66.21	-37.23	-11.49
EBIT Margin	-46.79%	-50.43%	-57.98%	-88.44%	-67.78%	-27.08%
Revenue as Reported	79.96	81.67	96.63	74.86	54.92	42.44
Advertising Expenses	-	1.23	2.33	4.64	-	-

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q